Skip to content
Open access

Whole transcriptome analysis reveals ELK3 as a key driver of metastasis through regulation of 3D migration and stemness in triple-negative breast cancer cells

Jul 2026 · bioRxiv · 0 citations · 35 references
Biology

TL;DR

Overall, ELK3 acts as a pro-metastatic regulator in TNBC by promoting migration and stemness.

Read PDF

Similar papers

Jul 2026

EFO2 promotes triple-negative breast cancer progression and reduces CD8+ T cell-mediated killing by acetylating USF1 to enhance SLC2A1-mediated glycolysis.

A novel EFO2/USF1/SLC2A1 signaling axis that modulates glycolytic metabolism and CD8⁺T cell cytotoxicity is identified, positioning EFO2 as a promising therapeutic target for TNBC treatment.

Lin Jia, Liru Li, Junning Peng et al. · 0 citations
Open access Aug 2026

TPD52 promotes breast cancer cell migration, invasion and proliferation via activation of the MAPK/ERK signaling pathway

Elevated TPD52 expression was associated with longer overall survival in specific subgroups, including the basal-like subtype, invasive lobular carcinoma, and N0/N1 stages, and a random forest-based diagnostic model demonstrated high accuracy across multiple datasets.

J. Yu, Z. Zhu, R. Deng et al. · 0 citations
Aug 2026

The miR-338-5p/METTL3 axis regulates m6A modification to inhibit tumor progression in triple-negative breast cancer.

This study reveals post-transcriptional regulation of METTL3 by miR-338-5p by confirming a functional miR-338-5p/METTL3/m6A axis in TNBC and targeting this distinct regulatory axis represents a promising therapeutic strategy for TNBC.

Wen-Jia Chen, Ya Xu, Yang-Zheng Lan et al. · 0 citations
Open access Sep 2026

miR-424-5p Regulates Stem-like and Malignant Phenotypes in Osteosarcoma by Targeting FZD4

Investigation of the role of frizzled class receptor 4 in OS progression found that it is highly expressed in OS and is associated with poor prognosis, and miR-424-5p can regulate these tumor-promoting effects by targeting FZD4.

Jing-Jin Ma, Yi Yang, Tong Liu et al. · 0 citations
Open access Jul 2026

METTL3 modulates cell viability and motility in HCC1143 and MDA-MB-231 triple-negative breast cancer cells

It is discovered that METTL3 depletion uniquely triggers a severe halt in cell division in HCC1143 cells, while universally disrupting actin-associated cell motility across different backgrounds, demonstrating that METTL3 acts as a context-dependent modulator of cell fate rather than a monolithic driver.

Buket Sağlam-Şen, Azime Akçaöz-Alasar, Ahmet Batuhan Dondurur et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.